RecallDepth
Class II Terminated

Lidocaine Hydrochloride Jelly USP, 2%, Sterile, 30mL tube, Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-711-31

Company
Akorn, Inc
Recall Initiated
August 31, 2022
Posted
September 14, 2022
Recall Number
D-1495-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
82,689 tubes
Firm Location
Gurnee, IL, United States

Reason for Recall

cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.

Distribution

USA nationwide

Lot / Code Info

Lot # 9J36A, 9J36B, 9J39A, 9J39B, 9J39C, 9J39D, 9J39E, 9J42B, 9J42C, Exp 8/31/2022; 9K62A, 9K62B, 9K62C, Exp 9/30/2022; 9M04A, 9M04B, Exp 11/30/2022

More recalls by Akorn, Inc

View all recalls by this company →

Other recent Class II Drug recalls